Table 1:
Age (years) | mean 64.0 (43–82) |
Gender | |
Male | 62 (43.4%) |
Female | 81 (56.6%) |
Tumour size (cm) | mean 0.8 (0.3–1.0) |
Location | |
Right | 78 (54.5%) |
Upper lobe | 49 (34.2%) |
Middle lobe | 14 (9.8%) |
Lower lobe | 15 (10.5%) |
Left | 65 (45.5%) |
Upper lobe | 27 (18.9%) |
Lower lobe | 38 (26.6%) |
Histology | |
Ad | 127 (88.8%) |
Sq | 7 (4.9%) |
Others | 9 (6.3%) |
Sm | 6 (4.2%) |
Pl | 2 (1.4%) |
AdSq | 1 (0.7%) |
pStage | |
pIA (pT1aN0) | 136 (95.1%) |
pIIA (pT1aN1) | 4 (2.8%) |
pIIIA (pT1aN2) | 3 (2.1%) |
Ad: adenocarcinoma; Sq: squamous cell carcinoma; Sm: small-cell carcinoma; Pl: pleomorphic carcinoma; AdSq: adenosquamous carcinoma.